BRPI0608178A2 - derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos - Google Patents

derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos

Info

Publication number
BRPI0608178A2
BRPI0608178A2 BRPI0608178-9A BRPI0608178A BRPI0608178A2 BR PI0608178 A2 BRPI0608178 A2 BR PI0608178A2 BR PI0608178 A BRPI0608178 A BR PI0608178A BR PI0608178 A2 BRPI0608178 A2 BR PI0608178A2
Authority
BR
Brazil
Prior art keywords
manufacture
pharmaceutical composition
pharmaceutical
aminopyrazole derivatives
pharmaceutical agents
Prior art date
Application number
BRPI0608178-9A
Other languages
English (en)
Inventor
Guy Georges
Bernhard Goller
Klaus-Peter Kuenkele
Aude Lemarchand
Anja Limberg
Ulrike Reiff
Matthias Rueth
Petra Rueger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0608178A2 publication Critical patent/BRPI0608178A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DE AMINOPIRAZOL, SUA FABRICAçãO, COMPOSIçãO FARMACêUTICA E USO COMO AGENTES FARMACêUTICOS. A presente invenção refere-se aos compostos de fórmula (1), seus sais farmaceuticamente aceitáveis, formas enantioméricas, diastereolsómeros e racematos, a preparação dos compostos, acima mencionados, medicamentos contendo-os e sua fabricação, bem como o uso dos compostos acima no controle ou na prevenção de enfermidades tal como cancer.
BRPI0608178-9A 2005-04-14 2006-03-17 derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos BRPI0608178A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05008111 2005-04-14
EP05008224 2005-04-14
PCT/EP2006/002478 WO2006108489A1 (en) 2005-04-14 2006-03-17 Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents

Publications (1)

Publication Number Publication Date
BRPI0608178A2 true BRPI0608178A2 (pt) 2009-11-17

Family

ID=36406561

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608178-9A BRPI0608178A2 (pt) 2005-04-14 2006-03-17 derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos

Country Status (10)

Country Link
US (1) US7462639B2 (pt)
EP (1) EP1879894A1 (pt)
JP (1) JP2008535876A (pt)
KR (1) KR20070113286A (pt)
AU (1) AU2006233537A1 (pt)
BR (1) BRPI0608178A2 (pt)
CA (1) CA2603204A1 (pt)
IL (1) IL185484A0 (pt)
MX (1) MX2007012477A (pt)
WO (1) WO2006108489A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010077839A1 (en) * 2008-12-15 2010-07-08 Wyeth Llc (Formerly Known As Wyeth) Substituted oxindol cb2 agonists for pain treatment
US9369371B2 (en) 2012-10-05 2016-06-14 Cisco Technologies, Inc. Method and system for path monitoring using segment routing
US9049233B2 (en) 2012-10-05 2015-06-02 Cisco Technology, Inc. MPLS segment-routing
US10419334B1 (en) 2012-12-27 2019-09-17 Sitting Man, Llc Internet protocol routing methods, systems, and computer program products
US10397100B1 (en) 2012-12-27 2019-08-27 Sitting Man, Llc Routing methods, systems, and computer program products using a region scoped outside-scope identifier
US10476787B1 (en) 2012-12-27 2019-11-12 Sitting Man, Llc Routing methods, systems, and computer program products
US10411997B1 (en) 2012-12-27 2019-09-10 Sitting Man, Llc Routing methods, systems, and computer program products for using a region scoped node identifier
US10397101B1 (en) 2012-12-27 2019-08-27 Sitting Man, Llc Routing methods, systems, and computer program products for mapping identifiers
US10404583B1 (en) 2012-12-27 2019-09-03 Sitting Man, Llc Routing methods, systems, and computer program products using multiple outside-scope identifiers
US10374938B1 (en) 2012-12-27 2019-08-06 Sitting Man, Llc Routing methods, systems, and computer program products
US10419335B1 (en) 2012-12-27 2019-09-17 Sitting Man, Llc Region scope-specific outside-scope indentifier-equipped routing methods, systems, and computer program products
US10587505B1 (en) 2012-12-27 2020-03-10 Sitting Man, Llc Routing methods, systems, and computer program products
US10447575B1 (en) 2012-12-27 2019-10-15 Sitting Man, Llc Routing methods, systems, and computer program products
US10404582B1 (en) 2012-12-27 2019-09-03 Sitting Man, Llc Routing methods, systems, and computer program products using an outside-scope indentifier
US10411998B1 (en) 2012-12-27 2019-09-10 Sitting Man, Llc Node scope-specific outside-scope identifier-equipped routing methods, systems, and computer program products
US10904144B2 (en) 2012-12-27 2021-01-26 Sitting Man, Llc Methods, systems, and computer program products for associating a name with a network path
US10212076B1 (en) 2012-12-27 2019-02-19 Sitting Man, Llc Routing methods, systems, and computer program products for mapping a node-scope specific identifier
US9537718B2 (en) 2013-03-15 2017-01-03 Cisco Technology, Inc. Segment routing over label distribution protocol
US10341221B2 (en) 2015-02-26 2019-07-02 Cisco Technology, Inc. Traffic engineering for bit indexed explicit replication
US11140074B2 (en) 2019-09-24 2021-10-05 Cisco Technology, Inc. Communicating packets across multi-domain networks using compact forwarding instructions
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA968347A (en) 1968-09-09 1975-05-27 John F. Gerster Substituted pyrazoles and process
US4282361A (en) 1978-03-16 1981-08-04 Massachusetts Institute Of Technology Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines
DE3410168A1 (de) 1984-03-20 1985-09-26 Boehringer Mannheim Gmbh, 6800 Mannheim Neue isochinolin-dione, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
PL144822B1 (en) 1984-05-12 1988-07-30 Boehringer Mannheim Gmbh Method of obtaining novel pyrolobenzimidazoles
US4835280A (en) 1985-01-18 1989-05-30 Boehringer Mannheim Gmbh Indoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazoles
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3618135A1 (de) 1986-05-30 1987-12-03 Bayer Ag Verfahren zur herstellung von oxetan-3-carbonsaeuren
DE3642315A1 (de) 1986-12-11 1988-06-23 Boehringer Mannheim Gmbh Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3701277A1 (de) 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3803775A1 (de) 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE4027592A1 (de) 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
WO1993019059A1 (en) 1992-03-25 1993-09-30 Pfizer Limited Antiviral peptides
GB9210744D0 (en) 1992-05-20 1992-07-08 Pfizer Ltd Antiviral peptides
US5700823A (en) 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
JP2890267B2 (ja) 1994-02-23 1999-05-10 ファイザー インク． ４−ヘテロサイクリル−置換キナゾリン誘導体、その調製法および抗癌剤としてのその使用法
ATE315654T1 (de) 1995-12-18 2006-02-15 Sugen Inc Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
ZA986729B (en) 1997-07-29 1999-02-02 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
CN1159315C (zh) 1998-12-17 2004-07-28 霍夫曼-拉罗奇有限公司 4,5-吡咯并羟吲哚
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
AU763618B2 (en) 1999-02-10 2003-07-31 Astrazeneca Ab Quinazoline derivatives as angiogenesis inhibitors
TWI262914B (en) 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
GB9922171D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
AU763242B2 (en) 1999-09-21 2003-07-17 Astrazeneca Ab Quinazoline compounds and pharmaceutical compositions containing them
GB9922173D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
CA2384291A1 (en) 1999-09-21 2001-03-29 Astrazeneca Ab Quinazoline derivatives and their use as pharmaceuticals
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
US6977259B2 (en) 2000-01-28 2005-12-20 Astrazeneca Ab Quinoline derivatives and their use as aurora 2 kinase inhibitors
BR0109828A (pt) 2000-04-07 2002-12-17 Astrazeneca Ab Composto, processo para a prepapação do mesmo ou de um sal deste, composição farmacêutica, uso do composto ou de um sal deste farmaceuticamente aceitável, e, método para a produção de um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente em necessidade de tal tratamento
CN100355750C (zh) 2000-09-15 2007-12-19 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的吡唑化合物
ATE326462T1 (de) 2000-12-21 2006-06-15 Vertex Pharma Pyrazolverbindungen als protein-kinase- inhibitoren
ATE339418T1 (de) 2001-06-01 2006-10-15 Vertex Pharma Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
AU2002334217B2 (en) 2001-10-26 2008-07-03 Aventis Pharmaceuticals Inc. Benzimidazoles and analogues and their use as protein kinases inhibitors
US6846928B2 (en) 2002-03-15 2005-01-25 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
AU2003218215A1 (en) 2002-03-15 2003-09-29 Vertex Pharmaceuticals, Inc. Azolylaminoazines as inhibitors of protein kinases
EP1485100B1 (en) 2002-03-15 2010-05-05 Vertex Pharmaceuticals Incorporated Azinylaminoazoles as inhibitors of protein kinases
ATE433973T1 (de) 2002-03-15 2009-07-15 Vertex Pharma Azolylaminoazine als inhibitoren von proteinkinasen
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
US7361665B2 (en) 2002-07-09 2008-04-22 Vertex Pharmaceuticals Incorporated Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
TWI372050B (en) 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
EP1598353A1 (en) 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
TW200626149A (en) 2004-09-24 2006-08-01 Hoffmann La Roche Tricycles, their manufacture and use as pharmaceutical agents

Also Published As

Publication number Publication date
KR20070113286A (ko) 2007-11-28
AU2006233537A1 (en) 2006-10-19
CA2603204A1 (en) 2006-10-19
US20060235065A1 (en) 2006-10-19
MX2007012477A (es) 2007-11-08
WO2006108489A1 (en) 2006-10-19
JP2008535876A (ja) 2008-09-04
IL185484A0 (en) 2008-01-06
EP1879894A1 (en) 2008-01-23
US7462639B2 (en) 2008-12-09

Similar Documents

Publication Publication Date Title
BRPI0608178A2 (pt) derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos
BRPI0519567A2 (pt) heterociclos tricÍclicos, sua fabricaÇço e uso como agentes farmacÊuticos
BRPI0508485A (pt) compostos de pentafluorsulfanila, sua fabricação e uso como agentes farmacêuticos
BRPI0515885A (pt) derivados de ftalazinona, sua preparação e uso como agentes farmacêuticos
BRPI0512330A (pt) derivados de pirazol-pirimidina
BRPI0417458A (pt) compostos inibidores de dpp-iv, sais faramaceuticamente aceitáveis e pró-fármacos do mesmo, seus processos de preparação, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos na fabricação de medicamento
BRPI0410477A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, método para a profilaxia ou tratamento de uma condição quiral em um mamìfero, formulação farmacêutica, combinação, uso de um composto, e, processo para preparar um composto
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
BRPI0509368A (pt) antagonistas cgrp selecionados, processo para a sua fabricação bem como seu uso como medicamento
BRPI0512335A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e sua utilização
UA94725C2 (en) [1h- indol- 5 -yl)-heteroaryloxy]-(1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
BRPI0414548A8 (pt) derivados de 2-piridona como inibidores de elastase de neutrófilo e seu uso
BRPI0516454A (pt) compostos, processo para a preparação de um composto, composição farmacêutica que o compreende, sua utilização, método para o tratamento e profilaxia de enfermidades, e de diabetes do tipo ii
BRPI0513287A (pt) derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
DK1869038T3 (da) Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler
NO20084177L (no) Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler
IL191748A0 (en) 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
BRPI0409878A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BR112014015327A2 (pt) carboxamidas heterocíclicas como moduladores da atividade da quinase
DE602007010038D1 (de) Pyrimidylderivate als proteinkinaseinhibitoren
BRPI0511523A (pt) derivados de tioéter, processo para preparação dos mesmos, composição farmacêutica e uso dos referidos derivados
MEP54208A (en) Medicaments containing steroids and a novel anticholinesterase drug
BRPI0508925A (pt) derivados de éter, produção e uso deles como agentes farmacêuticos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]